Modulation of insulin-like growth factor-I system of the bladder using a somatostatin analogue in chronic spinalized rats

Journal of Urology

Volumn 168, Issue 3, 2002, Pages 1253-1258

  Abdel Karim, A M ^a,b   Abdel Gawad, M ^a,b   Huynh, H ^a,b   Elhilali, M M ^a,b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bladder; Insulin like growth factor I; Rats, Sprague Dawley; Somatostatin; Spinal cord injuries

Indexed keywords

MITOGENIC AGENT; OCTREOTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CAPACITY; CONTROLLED STUDY; CYSTOMETRY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; MUSCLE HYPERTROPHY; NEUROGENIC BLADDER; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; URODYNAMICS;

EID: 0036720017     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64635-6     Document Type: Article

References (47)

1. Urodynamics of spinal cord injury
2. Diagnosis and treatment of bladder dysfunction in spinal cord injury patients
3. Neurogenic vesical dysfunction
4. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thicker media and a larger umber of smooth muscle layers
5. Hypertrophy of intestinal smooth muscle
6. Structural and mechanical alterations in hypertrophic venous smooth muscle
7. Update on bladder smooth-muscle physiology
8. Effects of partial outlet obstruction of the rat urinary bladder on micturition characteristics, DNA synthesis and the contractile response to field stimulation and pharmacological agents
9. Collagen content in the rat urinary bladder subjected to infravesical outflow obstruction
10. Detrusor hyperplasia and expression of "immediate early" genes with onset of abnormal urodynamic parameters
11. The effects of insulin-like growth factor on tumorigenesis and neoplastic growth
12. Insulin-like growth factor binding proteins and their role in controlling IGF actions
13. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells
14. Does an IGF-binding protein (IGFBP) present in involuting rat mammary gland regulate apoptosis?
15. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
16. Increase in insulin-like growth factor I in hypertrophying smooth muscle
17. Alteration of the insulin-like growth factor system of mitogens in hyperplastic bladders of paraplegic rats
18. In vitro and in vivo studies of antagonistic effects of human growth hormone analogs
19. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone
20. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7, 12-dimethylbenz(a)-anthracene-induced rat mammary carcinomas
21. Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue
22. Insulin-like growth factor-I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780
23. Micturition in rats: A chronic model for study of bladder function and effect of anesthetics
24. Changes in micturition after spinal cord injury in conscious rats
25. Effects of capsaicin on micturition and associated reflexes in chronic spinal rats
26. Spinal cord injury
27. Spinal cord injury
28. Reduced growth of human breast cancer xenografts in hosts homozygous for the 'lit' mutation
29. Interference of the IGF system as a strategy to inhibit breast cancer growth
30. Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I
31. Peptide neurons in peripheral tissues including the urinary tract: Immunohistochemical studies
32. A histochemical and immunohistochemical study of the autonomic innervation of the lower urinary tract of the female pig. Is the pig a good model for human bladder and urethra?
33. Localization of muscarinic on somatostatin-like immunoreactive neurones of the newborn guinea pig urinary bladder in culture
34. Changes in bladder and external urethral sphincter function after spinal cord injury in the rat
35. Effects of urinary diversion on the recovery of micturition reflexes after spinal cord injury in rats
36. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
37. Effective and lasting growth-hormone suppression in the active acromegaly with oral administration of somatostatin analogue SMS 210-995
38. Somatostatin and somatostatin analogues: Pharmacokinetics and pharmacodynamic effects
39. Direct effects of somatostatin analog octreotide on insulin-like growth factor-I in the arterial wall
40. Long-term treatment of refractory neonatal hypoglycemia with long acting somatostatin analog
41. Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child
42. Successful treatment of idiopathic secretory diarrhea of infancy with the somatostatin analogue SMS 201-995
43. Long-term use of somatostatin analogue SMS 201-995 in the treatment of hypoglycaemia due to nesidioblastosis
44. Use of a long acting somatostatin analogue in controlling ileostomy diarrhoea in infants
45. Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome
46. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients